Archive | Pharmaceutical Services

RSS feed for this section

Toward Building Resilient Pharmaceutical Systems: SIAPS Final Report

SIAPS final report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs.

Read full story · Comments are closed

Containing Antimicrobial Resistance through Rational Antimicrobial Use in Namibia

The SIAPS-developed AMR coalition-based strategy identifies educational institutions, such as UNAM; therapeutic committees (TCs); and key institutions involved in AMR, such as the National Institute of Pathology (NIP) as key players in the pre- and in-service training of health care professionals to enhance RMU and combat AMR. SIAPS collaborated with key institutions, including the MoHSS, Div:PhSs, UNAM-SOM, UNAM-SOP, NIP, and TCs in the Kunene and Karas regions, in activities to reduce hospital-acquired infections (HAIs); improve infection prevention and control (IPC); and promote RMU in Namibia.

Read full story · Comments are closed

Community-based Group ARV Dispensing Improves ART Services in Namibia

The US Ambassador to Namibia, H.E. Thomas F. Daughton, launched CBART group ARV refills on June 1, 2017. These groups are implemented widely in Onandjokwe and other districts in northern Namibia, where the HIV burden is high. During the CBART group ARV refill initiative launch, the ambassador remarked “simple solutions = best solutions; bring the pharmacy to the people rather than sending people to the pharmacy”. Since then, SIAPS has been supporting Namibia’s Ministry of Health and Social Services (MoHSS) and partners to implement this initiative. The MoHSS, with support of partners, has decentralized ART services to achieve the ambitious UNAIDS 90-90-90 targets for ending the AIDS epidemic by 2020. Although Namibia faces a high HIV burden, with approximately 220,000 living with HIV, the MoHSS has successfully expanded its ART patient coverage to more than 80%. With more than 150,000 people receiving ART from public health facilities countrywide, the MoHSS is making efforts to ensure retention of ART clients on treatment to minimize the development of HIV drug resistance.

Read full story · Comments are closed

Combating AMR with strong coalitions: Implementation experiences at the national and regional levels

Antimicrobial resistance (AMR) occurs when a microorganism becomes resistant to a drug that was originally effective for treating the infections it caused. It is one of the world’s most pressing global health threats and could erode progress made thus far in the treatment of HIV/AIDS, TB, malaria, and many other infectious diseases. Management Sciences for […]

Read full story · Comments { 0 }

Development of Swaziland’s National Antimicrobial Resistance Containment Strategic Plan

SIAPS has been proactive in supporting Swaziland in various areas of the pharmaceutical sector, which has contributed to the containment of antimicrobial resistance. During the process of developing the National AMR Containment Strategic Plan, the stakeholders and the AMR committee have learned valuable lessons—in particular, the importance of the One Health approach, as well as the leadership and collaboration, financial and technical capacity required not only for the development of the strategic plan, but also for its implementation. Understanding the One Health approach at the early stages of the process is helpful in leadership and in collaboration with national and international stakeholders, and securing stakeholders’ technical and financial commitment, in addition to the government’s investment in the implementation of the strategic plan. SIAPS’ timely technical support played a key part in finalizing the National AMR Containment Strategic Plan.

Read full story · Comments are closed

Sustaining SIAPS’ impact: What’s next for pharmaceutical systems strengthening?

By Francis Aboagye-Nyame, SIAPS program director Greatjoy Mazibuko was a pharmacist at the Oshakati Intermediate Hospital in Namibia working with ART patients. Every day, he rose at dawn, not knowing how many patients he would have that day. He often worked for 12 hours or more; patients were kept waiting for hours, perhaps having traveled […]

Read full story · Comments { 0 }

Advancing the Antimicrobial Drug Quality Agenda through Coalition Building: Lessons from AMR Response

A presentation by Mohan P. Joshi, Principal Technical Advisor and Lead for Pharmaceutical Services, SIAPS. Presented at a side event during the 2018 Prince Mahidol Awards Conference on the theme “Monitoring and Improving Medicines Quality through AMR National Action Plans”, organized by USP, USAID, the Thai Food and Drug Authority, and the Thai Department of Medical Sciences on January 29, 2018 in Bangkok, Thailand.

Read full story · Comments are closed

Toward Building Resilient Pharmaceutical Systems: SIAPS Final Report

SIAPS Final Report showcases achievements across 46 countries. Interventions are described by intermediate results and health areas and demonstrate how SIAPS successfully worked with a range of stakeholders, including Ministries of Health, to bolster pharmaceutical systems and address country-specific needs.

Read full story · Comments { 0 }

SIAPS end-of-program event looks toward future of pharmaceutical systems strengthening

On Thursday, March 1, 2018, MSH held an end-of-program event for the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) program. More than 100 attendees gathered in Arlington, VA, to discuss progress made and opportunities toward ensuring that quality, life-saving essential medicines and services are available and affordable for the world’s poorest and […]

Read full story · Comments { 0 }

SIAPS by the Numbers

This infographic provides an overview of select SIAPS interventions and results in line with six core health system functions: governance; capacity building; information for decision-making; financing; supply chain; and pharmaceutical services.

Read full story · Comments are closed